A business in context

CVKD research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-08 · 8005 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-08-31 · 0001213900-26-095394 · Items 7.01,8.01,9.01

  2. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001213900-26-089153

  3. 8-K · Current report

    Report date 2026-08-13 · 0001213900-26-089147 · Items 2.02,9.01

  4. DEF 14A · Proxy statement

    Report date 2026-09-24 · 0001213900-26-084710

  5. 8-K · Current report

    Report date 2026-07-21 · 0001213900-26-079824 · Items 7.01,8.01,9.01

  6. 8-K · Current report

    Report date 2026-07-14 · 0001213900-26-079176 · Items 5.02,9.01

  7. 8-K · Current report

    Report date 2026-07-07 · 0001213900-26-077134 · Items 5.02,9.01

  8. 4 · Ownership change

    Report date 2026-06-29 · 0001213900-26-074557

  9. 8-K · Current report

    Report date 2026-06-30 · 0001213900-26-074421 · Items 1.01,3.02,8.01,9.01

  10. 8-K · Current report

    Report date 2026-06-25 · 0001213900-26-073213 · Items 5.02,9.01

  11. 4 · Ownership change

    Report date 2026-06-25 · 0001213900-26-072789

  12. 4 · Ownership change

    Report date 2026-06-22 · 0001213900-26-071578

  13. 4 · Ownership change

    Report date 2026-06-16 · 0001213900-26-070248

  14. 8-K · Current report

    Report date 2026-06-18 · 0001213900-26-069902 · Items 7.01,8.01,9.01

  15. 4 · Ownership change

    Report date 2026-06-11 · 0001213900-26-068981

  16. 4 · Ownership change

    Report date 2026-06-08 · 0001213900-26-067484

  17. 4 · Ownership change

    Report date 2026-06-03 · 0001213900-26-065925

  18. 8-K · Current report

    Report date 2026-05-28 · 0001213900-26-064744 · Items 5.02,9.01

  19. 4 · Ownership change

    Report date 2026-05-29 · 0001213900-26-064357

  20. 8-K · Current report

    Report date 2026-05-07 · 0001213900-26-053075 · Items 2.02,9.01

  21. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001213900-26-053074

  22. 8-K · Current report

    Report date 2026-04-30 · 0001213900-26-049754 · Items 7.01,8.01,9.01

  23. 8-K · Current report

    Report date 2026-03-31 · 0001213900-26-038014 · Items 1.01,3.02,3.03,9.01

  24. 10-K · Annual report

    Report date 2025-12-31 · 0001213900-26-036946

  25. 8-K · Current report

    Report date 2026-03-31 · 0001213900-26-036937 · Items 2.02,9.01

  26. 8-K · Current report

    Report date 2026-03-12 · 0001213900-26-026646 · Items 7.01,8.01,9.01

  27. 8-K · Current report

    Report date 2026-02-24 · 0001213900-26-019606 · Items 8.01,9.01

  28. 8-K · Current report

    Report date 2025-12-23 · 0001213900-25-125433 · Items 8.01,9.01

  29. 8-K · Current report

    Report date 2025-12-15 · 0001213900-25-121932 · Items 1.01,3.02,9.01

  30. 8-K · Current report

    Report date 2025-12-10 · 0001213900-25-120360 · Items 1.01,7.01,8.01,9.01

  31. 8-K · Current report

    Report date 2025-11-24 · 0001213900-25-116307 · Items 5.02,8.01,9.01

  32. 8-K · Current report

    Report date 2025-11-18 · 0001213900-25-112123 · Items 8.01,9.01

  33. 8-K · Current report

    Report date 2025-11-10 · 0001213900-25-107949 · Items 2.02,9.01

  34. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001213900-25-107816

  35. 8-K · Current report

    Report date 2025-09-24 · 0001213900-25-091109 · Items 5.07

  36. 8-K · Current report

    Report date 2025-09-12 · 0001213900-25-087461 · Items 1.01,7.01,8.01,9.01

  37. 8-K · Current report

    Report date 2025-08-11 · 0001213900-25-074355 · Items 2.02,9.01

  38. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001213900-25-073885

  39. 8-K · Current report

    Report date 2025-08-05 · 0001213900-25-071764 · Items 8.01,9.01

  40. DEF 14A · Proxy statement

    Report date 2025-09-24 · 0001213900-25-069612

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 21 transaction rows21SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

21 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-26
2026-06-26
Pham Quang X
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock9029.03.05
2026-06-25
2026-06-26
Pham Quang X
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock2127.03.0
2026-06-23
2026-06-24
Pham Quang X
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock2277.03.2
2026-06-22
2026-06-24
Pham Quang X
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock9167.03.55
2026-06-17
2026-06-18
Pham Quang X
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock513.03.16
2026-06-16
2026-06-18
Pham Quang X
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock3613.03.18
2026-06-15
2026-06-15
Pham Quang XS · Sale
Disposed
Common Stock3666.03.58
2026-06-12
2026-06-15
Pham Quang XS · Sale
Disposed
Common Stock12996.03.94
2026-06-11
2026-06-15
Pham Quang XS · Sale
Disposed
Common Stock1462.04.12
2026-06-10
2026-06-10
Pham Quang X
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock3500.04.21
2026-06-09
2026-06-10
Pham Quang X
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock12992.04.06
2026-06-08
2026-06-10
Pham Quang X
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock5893.04.38
2026-06-05
2026-06-05
Pham Quang X
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock2064.04.42
2026-06-04
2026-06-05
Pham Quang X
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock3898.04.41
2026-06-03
2026-06-05
Pham Quang X
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock2323.04.26
2026-06-02
2026-06-02
Pham Quang X
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock349.04.46
2026-05-29
2026-06-02
Pham Quang X
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock303.05.01
2026-05-28
2026-05-29
Pham Quang X
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock2989.04.93
2026-05-22
2026-05-26
Pham Quang X
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock1165.05.69
2026-05-12
2026-05-29
Pham Quang X
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock3298.05.28
2026-05-11
2026-05-29
Pham Quang X
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock6476.05.76

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001937993Cadrenal Therapeutics, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    No USD annual revenue periods with complete CPI coverage are available. Non-USD statements are not converted with U.S. CPI.

    Bureau of Labor Statistics · retrieved 2026-09-08 · 9 selected series; gaps remain missing

    Explore the CPI history ↗